San Diego, CA -- (SBWire) -- 02/01/2023 --An investigation was announced for investors of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares over potential securities laws violations by Ginkgo Bioworks Holdings, Inc.
Investors who purchased shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Ginkgo Bioworks Holdings, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Boston, MA based Ginkgo Bioworks Holdings, Inc. develops platform for cell programming.
On September 14, 2021, Soaring Eagle Acquisition Corp. (Nasdaq: SRNGU, SRNG, SRNGW) announced that its business combination (with Ginkgo Bioworks, Inc. ("Ginkgo") was approved in a shareholder vote. Upon the closing of the Business Combination, Ginkgo Bioworks Holdings, Inc said it expected to receive $1.633 billion of gross proceeds, including $775 million in committed funding from a PIPE plus approximately $858 million from the Soaring Eagle trust account.
Shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) began trading on the NYSE on September 17, 2021.
Since then shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) declined to $1.45 per share in early January 2023.
Those who purchased shares of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Investigation Announced for Investors Who Lost Money with NYSE: DNA Shares over Possible Violations of Securities Laws by Ginkgo Bioworks Holdings, Inc.
An investigation for investors in Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares over potential securities laws violations by Ginkgo Bioworks Holdings, Inc. was announced.